Dear Friends & Colleagues,
We invite you to join us for the 5th Annual Heart in Diabetes (HiD) CME Conference, a unique and exciting multidisciplinary program: Where the Heart, Kidney, and Diabetes Meet in Clinical Practice. The meeting will take place September 10-12, 2021, at the Sheraton Times Square Hotel in New York City. This year the conference will be a hybrid, combining live in-person and live-online followed by 90 days of on-demand access.
Since its inception in 2017, the HiD Conference has convened experts and practicing clinicians in a one-of-a-kind scientific meeting to share knowledge and best practices for managing patients with diabetes and cardio-renal-metabolic disorders in a state-of-the-art clinical program. This unique forum has emerged as a major effort to help clinicians improve care for patients with diabetes, cardiovascular disease (CVD), chronic kidney disease (CKD), heart failure (HF), and related conditions. These disorders share many pathological features and often occur in the same individual, but until recently they were treated as separate conditions. However, a wealth of evidence from recent trials have demonstrated cardiovascular benefits from agents that control blood glucose, lipids, blood pressure, and inflammation in people with diabetes, which supports a multi-specialty approach to patient care. Nevertheless, among practicing professionals, including experts, there is a gap in understanding the implications of these new developments on disease management. The HiD Conference will address this gap by examining the newest outcome data and providing clinicians with strategies for implementing this evidence base into everyday clinical practice.
Each year, the HiD Conference is a rousing success, with progressive growth in attendance and impressive conference evaluations. Over 2,400 clinicians from 76 countries registered for the 2020 HiD meeting. The evaluations were remarkable, rating the overall quality of the meeting at 98%. Ninety-eight percent of participants stated that they will recommend the meeting to others and will return the next year.
The 5th HiD award, the Luminary in Cardiometabolic Medicine Award, will be presented to Dr. Robert Eckel who will provide a keynote lecture. In addition, key sessions will include COVID-19 in DM and CVD; the contemporary approach to ASCVD and diabetes; joint symposia with the journals Circulation; recent diabetes publications in cardiology; diabetes and CVD in diverse populations; imaging of atherosclerosis; obesity, diabetes, and the heart; dyslipidemia; advanced technology; cardiovascular outcomes trials; guidelines update; management of diabetes in 2021; heart disease in women; and heart failure and CKD. Each session will promote lively discussion by means of panels and debates with robust opportunities for the audience to interact with faculty.
New this year, every day concludes with a one-hour panel discussion with featured faculty discussing and responding to questions, the implications to practice which were presented throughout the day. The meeting will also feature abstract presentations from scientists and researchers around the world, as well as several non-CME, industry-supported presentations.
Abstracts will be published in the American Heart Journal (www.journals.elsevier.com/american-heart-journal, Editor-in-Chief: Daniel Mark, MD, MPH).
If you are a cardiologist, endocrinologist, nephrologist, diabetologist, lipidologist, internist, or clinician with an interest in the science of the Heart in Diabetes, this meeting is for you! We personally invite you to join us in this exciting endeavor.
Register today! We look forward to seeing you in New York in September!